In breast cancer, upregulation of IFI6 in endosomes and mitochondria and the binding IFI6 with RAB+ endosomes dysregulate the mitochondrial resistance to apoptosis and thus ensued anti-apoptosis in cancer cells [48]. Here, IFI6 is linked to cancer.